A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Clinical trial NCT06424288 · RECRUITING
Trial details
- NCT number
- NCT06424288
- Sponsor
- Boehringer Ingelheim
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-17
- Primary completion
- 2028-05-22
- Enrollment
- 6000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.